FOR OUR RESPONSE TO THE COVID-19 PANDEMIC PLEASE CLICK HERE READ MORE

Genefirst have developed a COVID-19 test

August 24th 2020

We have developed a simple to use COVID-19 molecular diagnostic test which can be used in clinical laboratories to process patient samples and to detect those positive for COVID-19.

We have since extended this development to include other common flu season pathogens, such as Influenza and RSV in our test, to support effective screening and triage of symptomatic patients. With the support of our network across Europe we will be conducting clinical studies to determine the utility and effectiveness of adopting these assays into the healthcare system, such as the NHS. Whilst COVID development is a top priority, GeneFirst continues to develop and launch oncology tests for use with liquid biopsies, and to grow the team as part of the business plan for expansion. - Winnie Wu, CEO GeneFirst Limited

October 4th 2019

Head to Head: Wendy Tindsley, Innovation Director for Oxford Innovation

We sat down with Innovation Director, Wendy Tindsley to find out a bit more about her and how she is looking forward to helping businesses across Oxfordshire and at Culham Innovation Centre.

May 30th 2019

Customer Story – Plasmatreat UK

We spoke to Ray Potgeiter, about how Plasmatreat got started, what they are currently working on, and how they are finding Culham Innovation Centre so far.

November 1st 2018

Customer Story – GeneFirst

We spoke to Winnie Wu, Chief Operations Officer about how GeneFirst got started, what they are currently working on, and how they are finding Culham Innovation Centre so far.